Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Feldmann

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|December 19, 2003
Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritisAndrew D Foey, Sarah Field, Salman Ahmed, et al.
The Journal of Rheumatology|February 14, 2007
Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependentJan Bondeson, Sarah Lauder, Shane Wainwright, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signalingSandra M Sacre, Anna M C Lundberg, Evangelos Andreakos, et al.
Critical Care (London, England)|May 18, 2010
The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunctionNiccolò Terrando, António Rei Fidalgo, Marcela Vizcaychipi, et al.
Arthritis and Rheumatism|February 2, 2002
Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritisFionula M Brennan, Amanda L Hayes, Cathleen J Ciesielski, et al.
Circulation|December 2, 2009
Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosisClaudia Monaco, Scott M Gregan, Tina J Navin, et al.
Annals of the Rheumatic Diseases|November 21, 2007
Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissueSandra M Sacre, Stefan K Drexler, Evangelos Andreakos, et al.
Arthritis and Rheumatism|December 1, 2007
Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockadeJulia J Inglis, Clare A Notley, David Essex, et al.
NIHR Open Research|October 26, 2023
Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trialSally Hopewell, Nicola Kenealy, Ruth Knight, et al.
Arthritis Research & Therapy|October 11, 2011
Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockadeLuke L Gompels, Nasser M Malik, Leigh Madden, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|December 19, 2003
Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritisAndrew D Foey, Sarah Field, Salman Ahmed, et al.
The Journal of Rheumatology|February 14, 2007
Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependentJan Bondeson, Sarah Lauder, Shane Wainwright, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signalingSandra M Sacre, Anna M C Lundberg, Evangelos Andreakos, et al.
Critical Care (London, England)|May 18, 2010
The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunctionNiccolò Terrando, António Rei Fidalgo, Marcela Vizcaychipi, et al.
Arthritis and Rheumatism|February 2, 2002
Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritisFionula M Brennan, Amanda L Hayes, Cathleen J Ciesielski, et al.
Circulation|December 2, 2009
Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosisClaudia Monaco, Scott M Gregan, Tina J Navin, et al.
Annals of the Rheumatic Diseases|November 21, 2007
Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissueSandra M Sacre, Stefan K Drexler, Evangelos Andreakos, et al.
Arthritis and Rheumatism|December 1, 2007
Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockadeJulia J Inglis, Clare A Notley, David Essex, et al.
NIHR Open Research|October 26, 2023
Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trialSally Hopewell, Nicola Kenealy, Ruth Knight, et al.
Arthritis Research & Therapy|October 11, 2011
Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockadeLuke L Gompels, Nasser M Malik, Leigh Madden, et al.
Pageof 16